These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 9252716
1. Prognostic significance of proliferating cell nuclear antigen expression in transitional cell carcinoma of the upper urinary tract. Cheng HL, Chow NH, Tzai TS, Tong YC, Lin JS, Chan SH, Yang WH, Chang CC, Lin YM. Anticancer Res; 1997; 17(4A):2789-93. PubMed ID: 9252716 [Abstract] [Full Text] [Related]
10. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract. Chowdhury GM, Kojima K, Kanayama H, Tsuji M, Kurokawa Y, Kagawa S. Cancer; 1996 Aug 15; 78(4):827-33. PubMed ID: 8756378 [Abstract] [Full Text] [Related]
11. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer. Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ. Anticancer Res; 2002 Aug 15; 22(6B):3759-64. PubMed ID: 12552989 [Abstract] [Full Text] [Related]
12. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications. Popov Z, Gil-Diez-De-Medina S, Ravery V, Hoznek A, Bastuji-Garin S, Lefrere-Belda MA, Abbou CC, Chopin DK. Urol Oncol; 2004 Aug 15; 22(2):93-101. PubMed ID: 15082004 [Abstract] [Full Text] [Related]
13. Prognostic significance of tumor necrosis in primary transitional cell carcinoma of upper urinary tract. Lee SE, Hong SK, Han BK, Yu JH, Han JH, Jeong SJ, Byun SS, Park YH, Choe G. Jpn J Clin Oncol; 2007 Jan 15; 37(1):49-55. PubMed ID: 17204506 [Abstract] [Full Text] [Related]
14. [Apoptosis and expression of PCNA in superficial transitional cell bladder cancer as related to recurrence]. Chen L, Wang X, Mei H, Chen W. Zhonghua Wai Ke Za Zhi; 1998 Aug 15; 36(8):484-6. PubMed ID: 11825447 [Abstract] [Full Text] [Related]
15. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study. Yang TB, Zeng FH, Sun ZQ. Chin Med J (Engl); 2006 Nov 05; 119(21):1821-8. PubMed ID: 17097038 [Abstract] [Full Text] [Related]
16. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract. Kikuchi E, Horiguchi Y, Nakashima J, Hatakeyama N, Matsumoto M, Nishiyama T, Murai M. J Urol; 2005 Dec 05; 174(6):2120-3; discussion 2124. PubMed ID: 16280740 [Abstract] [Full Text] [Related]
17. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. Akdogan B, Dogan HS, Eskicorapci SY, Sahin A, Erkan I, Ozen H. J Urol; 2006 Jul 05; 176(1):48-52. PubMed ID: 16753365 [Abstract] [Full Text] [Related]
18. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. Catto JW, Azzouzi AR, Rehman I, Feeley KM, Cross SS, Amira N, Fromont G, Sibony M, Cussenot O, Meuth M, Hamdy FC. J Clin Oncol; 2005 May 01; 23(13):2903-10. PubMed ID: 15753461 [Abstract] [Full Text] [Related]
19. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma. Cai T, Nesi G, Boddi V, Mazzoli S, Dal Canto M, Bartoletti R. Oncol Rep; 2006 Aug 01; 16(2):329-34. PubMed ID: 16820911 [Abstract] [Full Text] [Related]
20. Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract. Nakanishi K, Tominaga S, Hiroi S, Kawai T, Aida S, Kasamatsu H, Aurues T, Hayashi T, Ikeda T. Virchows Arch; 2002 Dec 01; 441(6):559-63. PubMed ID: 12461612 [Abstract] [Full Text] [Related] Page: [Next] [New Search]